| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/13/2007 | US20070212420 Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives |
| 09/13/2007 | US20070212419 Synthesis of biocompatible nanocomposite hydrogels as a local drug delivery system |
| 09/13/2007 | US20070212418 Microparticles comprising somatostatin analogues |
| 09/13/2007 | US20070212417 Compressible resilient granules and formulations prepared therefrom |
| 09/13/2007 | US20070212416 Controlled Release Matrix Pharmaceutical Dosage Formulation |
| 09/13/2007 | US20070212415 Sustained-release tablet containing doxazosin mesylate |
| 09/13/2007 | US20070212414 Ethanol-resistant sustained release formulations |
| 09/13/2007 | US20070212413 Sustained-release oral molsidomine composition for treating atherosclerosis |
| 09/13/2007 | US20070212412 Stable solid formulation of sertindole |
| 09/13/2007 | US20070212411 Coating capsules with active pharmaceutical ingredients |
| 09/13/2007 | US20070212410 Compositions and methods for delivery of amino-functional drugs |
| 09/13/2007 | US20070212409 Stable pharmaceutical compositions for 2-aza-bicyclo [3.30]-octane-3-carboxylic acid derivatives |
| 09/13/2007 | US20070212408 Stable Pharmaceutical Composition Containing Benzimidazole Derivatives and Method of Manufacturing the Same |
| 09/13/2007 | US20070212407 Oral Composition A First Composition (A) And A Second Composition (B) As A Combination Product For Separate Or Consecutive Administration In The Cosmetic Treatment Of The Human Body |
| 09/13/2007 | US20070212406 Homeopathic drug composition and methods of use thereof |
| 09/13/2007 | US20070212405 Dispersion for pulmonary delivery of a bioactive agent |
| 09/13/2007 | US20070212404 Liposome And Method Of Preparing The Same |
| 09/13/2007 | US20070212403 Method for Selecting Cationic or Anionic Liposomes for Treatment of a Mucosa Membrane, and Kit Comprising the Same |
| 09/13/2007 | US20070212402 Patch |
| 09/13/2007 | US20070212401 Single-use cosmetic article comprising a support impregnated with a lotion containing oxyethylenated sorbitan monolaurate comprising 4 OE |
| 09/13/2007 | US20070212400 Modified Cyclodextrin Film Or Fiber, And Method For Producing The Same |
| 09/13/2007 | US20070212399 Pyroligneous liquor sheet |
| 09/13/2007 | US20070212398 Powdered wipe |
| 09/13/2007 | US20070212397 Pharmaceutical delivery device and method for providing ocular treatment |
| 09/13/2007 | US20070212391 Stabilised prostaglandin composition |
| 09/13/2007 | US20070212384 Altering Animal Waste Compositiion |
| 09/13/2007 | US20070212380 Conjugated Fatty Acid Based Emulsion and Methods for Preparing and Using Same |
| 09/13/2007 | US20070212346 Highly Concentrated Stabilized Igm Solution |
| 09/13/2007 | US20070212331 Methods and compositions for selectively killing cells |
| 09/13/2007 | US20070212326 Polyquaternary organosilicon compounds-containing composition |
| 09/13/2007 | US20070212310 Antimicrobial smoke flavor for oral microflora control |
| 09/13/2007 | US20070212308 Methods and compositions for treating asthma in human and non human primates |
| 09/13/2007 | US20070212307 Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same |
| 09/13/2007 | US20070212306 Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides |
| 09/13/2007 | US20070212303 Sterically stabilized liposomes with hydrophilic polymers on surface; computed tomography |
| 09/13/2007 | US20070210474 Divided Solid Compositions With A High Talc Content, Which Are Intended To Be Incorporated In A Thermoplastic Material |
| 09/13/2007 | US20070209660 Intranasal Opioid Compositions, Delivery Devices and Methods of Using Same |
| 09/13/2007 | US20070209552 Rheology control of pickering emulsions by electrolytes |
| 09/13/2007 | DE19901270B4 Verfahren zur Flüssigkultivierung von Schizophyllum commune Fr. zur Isolierung von β-1,6-verzweigtem-β-1,3-Glucan Process for the liquid cultivation of Schizophyllum commune Fr. for the isolation of β-1,6-branched-β-1,3-glucan |
| 09/13/2007 | DE102006042615A1 Sicherung der Stabilität von Phytomenadion-haltigen flüssigen Arzneimittelzubereitungen zum Einnehmen mittels Zusatz von 0,01% Natriumedetat Ensuring the stability of phytomenadione-containing liquid pharmaceutical preparations for internal use by the addition of 0.01% sodium edetate |
| 09/13/2007 | DE102006011881A1 Mixing apparatus for nano dispersion, from liquid and at least one liquid/solid additive, has closed housing with inner tube to take dispersion by suction in circular rotary recirculation |
| 09/13/2007 | DE102006011012A1 Verwendung von Zinkcysteinat zur Behandlung von Entzündungen oder Allergien der Atemwege Using Zinkcysteinat for treating inflammation or respiratory allergies |
| 09/13/2007 | CA2645679A1 Oral controlled release formulation for sedative and hypnotic agents |
| 09/13/2007 | CA2645320A1 Hormone replacement formulation |
| 09/13/2007 | CA2645080A1 Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same |
| 09/13/2007 | CA2645073A1 Transdermal drug delivery compositions and topical compositions for application on the skin |
| 09/13/2007 | CA2645070A1 Pharmaceutical composition for external use |
| 09/13/2007 | CA2644992A1 Ethanol-resistant sustained release formulations |
| 09/13/2007 | CA2644981A1 Pharmaceutical formulation comprising fluoroquinolones |
| 09/13/2007 | CA2644905A1 Ezetimibe compositions |
| 09/13/2007 | CA2644435A1 Dosage forms for administering combinations of drugs |
| 09/13/2007 | CA2644096A1 Aqueous moisturizers and lubricants and uses thereof |
| 09/13/2007 | CA2643903A1 Ocular therapy using sirtuin-activating agents |
| 09/13/2007 | CA2643015A1 Tablet formulations and processes |
| 09/13/2007 | CA2633443A1 Encapsulated phospholipid-stabilized oxidizable material |
| 09/12/2007 | EP1832298A1 Matrix-type controlled release preparation comprising basic substance or salt thereof, and process for production of the same |
| 09/12/2007 | EP1832292A1 Treatment of neurodegenerative disease through intracranial delivery of short interfering RNA (siRNA) |
| 09/12/2007 | EP1832288A1 Stable granular pharmaceutical composition of solifenacin or its salt |
| 09/12/2007 | EP1832285A1 Formulation comprising fenofibric acid or a physiologically acceptable salt thereof |
| 09/12/2007 | EP1832282A1 Band seal for hard capsule |
| 09/12/2007 | EP1832281A1 Process for producing a solid dispersion of an active ingredient |
| 09/12/2007 | EP1832280A1 Liposome allowing the discharge of substance entrapped therein from endosome |
| 09/12/2007 | EP1832279A2 A process for the preparation of suspensions of drug particles for inhalation delivery |
| 09/12/2007 | EP1832278A1 Zinc cysteinate for treating inflammations or allergies of the respiratory tracts |
| 09/12/2007 | EP1830886A1 Method for stabilizing anti-dementia drug |
| 09/12/2007 | EP1830884A1 Treatment of inflammatory diseases |
| 09/12/2007 | EP1830860A2 Stable non-dihydrate azithromycin oral suspensions |
| 09/12/2007 | EP1830857A2 Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone |
| 09/12/2007 | EP1830855A1 Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release |
| 09/12/2007 | EP1830851A2 Rapid disintegrating taste masked compositions and a process for its preparations |
| 09/12/2007 | EP1830849A1 Fast release dosage forms for antibiotics |
| 09/12/2007 | EP1830831A2 Pharmaceutical formulations of gallium salts |
| 09/12/2007 | EP1830824A1 Nanoparticle composition and methods for synthesis thereof |
| 09/12/2007 | EP1830823A2 Stable oral benzimidazole compositions and process of preparation thereof |
| 09/12/2007 | EP1830822A1 Stable pharmaceutical composition comprising an active substance in the form of solid solution |
| 09/12/2007 | EP1830820A1 Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof |
| 09/12/2007 | EP1830819A1 Stable pharmaceutical composition comprising amoxicillin and clavulanic acid |
| 09/12/2007 | EP1830818A1 Process for the manufacture of sterile suspensions or lyophilisates of low-soluble basic peptide complexes, pharmaceutical formulations comprising these complexes and their use as medicament |
| 09/12/2007 | EP1830817A1 Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it |
| 09/12/2007 | EP1830816A1 Solid dosage form comprising proton pump inhibitor and suspension made thereof |
| 09/12/2007 | EP1830815A1 Enteric coated azithromycin multiparticulates |
| 09/12/2007 | EP1830814A2 Taste masking system for non-plasticizing drugs |
| 09/12/2007 | EP1830813A2 Lipid particles comprising bioactive agents, methods of preparing and uses thereof |
| 09/12/2007 | EP1830812A2 Anti-viral uses of metal nanomaterial compositions |
| 09/12/2007 | EP1830811A2 Method for preparing a solid pharmaceutical composition with prolonged and controlled release by high pressure treatment |
| 09/12/2007 | EP1830810A1 Spray-dried composition containing collectin family proteins or variants therof and process for preparing the same |
| 09/12/2007 | EP1830809A2 Injectable non-aqueous suspension |
| 09/12/2007 | EP1830808A1 Plastic bottle for oxaliplatin solution |
| 09/12/2007 | EP1830807A1 A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 09/12/2007 | EP1830806A2 Sustained release formulation comprising bisphosphonate |
| 09/12/2007 | EP1830805A2 Compositions comprising polymeric emulsifiers and methods of using same |
| 09/12/2007 | EP1830804A2 Stable compositions of fenofibrate with fatty acid esters |
| 09/12/2007 | EP1830803A2 Medicament for hygienic application inside the ear |
| 09/12/2007 | EP1830802A2 Effervescent pressed gum tablet compositions |
| 09/12/2007 | EP1830801A2 Drop preparations comprising dimetindene |
| 09/12/2007 | EP1689483A4 Method for transdermal delivery of permeant substances |
| 09/12/2007 | EP1675539A4 Pretreatment method and system for enhancing transdermal drug delivery |
| 09/12/2007 | EP1545467B1 Solid pharmaceutical formulations comprising telmisartan |
| 09/12/2007 | EP1526860B1 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 09/12/2007 | EP1519962B1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring |